Keith C. Ellis, PhD, discusses his innovative approach to Long Covid treatment

Send us Fan MailIn this conversation, Brandy Schantz speaks with Dr. Keith Ellis about his research on long COVID, particularly focusing on the microclots hypothesis. They discuss the challenges faced by patients, the lack of clear diagnostic criteria, and the frustrations with the healthcare system. Dr. Ellis emphasizes the need for more focused research and the development of therapeutics to address the debilitating symptoms of long COVID. The conversation also touches on the role of natural products in drug development and the importance of accessibility and affordability in treatment options. In this conversation, Keith C. Ellis, PhD, discusses his innovative approach to developing natural supplements that mimic pharmaceutical effects, emphasizing the importance of patient empowerment and the need for open dialogue in healthcare. He critiques the bureaucratic inertia in medical research and advocates for immediate solutions to health issues, particularly in the context of long COVID. The discussion highlights the necessity of integrating natural remedies into patient care while navigating the complexities of modern medicine.Support the show